Reportable Segment Information (Tables)

12 Months Ended

Sep. 30, 2016

Segment Reporting [Abstract]

Segment Revenue, Operating Income and Depreciation and Amortization

The tables below present segment revenue, operating income from continuing operations and depreciation and amortization, for the years ended September 30, as follows (in thousands):

	2016			2015			2014
Revenue:
Medical Device	$	53,202		$	45,944		$	43,068
In Vitro Diagnostics		18,164			15,954			14,371
Total revenue	$	71,366		$	61,898		$	57,439
Operating income (loss):
Medical Device	$	16,975		$	21,192		$	22,636
In Vitro Diagnostics		7,115			4,484			3,459
Total segment operating income		24,090			25,676			26,095
Corporate		(7,231	)		(6,587	)		(7,519	)
Total operating income from continuing operations	$	16,859		$	19,089		$	18,576
Depreciation and amortization:
Medical Device	$	3,261		$	1,138		$	1,136
In Vitro Diagnostics		789			873			850
Corporate		823			794			729
Total depreciation and amortization	$	4,873		$	2,805		$	2,715

Revenue from Major Customers

Revenue from customers that equaled or exceeded 10% of total revenue was as follows for the years ended September 30:

	2016			2015			2014
Medtronic		25	%		26	%		19	%

Geographic Revenue

Geographic revenue was as follows for the years ended September 30:

	2016			2015			2014
Domestic		79	%		77	%		78	%
Foreign		21	%		23	%		22	%